Liver Cancer
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Apr 14, 2005; 11(14): 2061-2066
Published online Apr 14, 2005. doi: 10.3748/wjg.v11.i14.2061
Table 4 Compare the HBV infective pattern between SLHCC and NHCC.
Serum markersAll patients (n = 270)
Recurrent patients (n = 136)
χ2P
SLHCC ratio (%)NHCC ratio (%)SLHCC ratio (%)NHCC ratio (%)
HBsAg+HBeAg+HBcAb+40.013.333.325.04.2440.039
HBsAg+HBeAb+HBcAb+56.312.553.112.20.0030.955
HBsAg+HBcAb+70.212.873.111.50.0790.778
HBsAb+71.414.360.020.01.8330.176
HBeAb+HBcAb+75.012.50.0100.04.8760.000
HBsAg+63.25.350.012.54.8670.027
HBV negative69.64.387.50.04.8770.027